Navigate Fool.com
Will XON beat
the market?



Community Rating: 3 Stars: Appealing

21.10 0.00 (0.00%)

Quote as of

Extended Hours: $21.20 $0.10 (0.47%)
Quote as of (NYSE)

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $19.71
Previous Close $21.10
Daily Range $19.60 - $21.40
52-Week Range $17.52 - $38.50
Market Cap $2.1B
P/E Ratio -14.04
Dividend (Yield) $0.00 (0.0%)
Volume 1,413,743
Average Daily Volume 899,144
Current FY EPS -$0.22

How do you think XON
will perform against the market?

Top XON Bull/Bear Pitches


There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!


There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Can Natural Gas Help Intrexon Take the Lead in Isobutanol Development?

Synthetic biology is tackling low-cost natural gas as a feedstock for chemical production. What are the risks associated with such an approach?

Healthcare Stocks Mixed; Intrexon Falls After Q4 EPS, Revenue Lag Expectations

Sector Update: Healthcare

Stocks: Insiders Buy at Intrexon, Liquidity Services, and Hercules Offshore

Plus, a purchase at PennyMac Financial Services.

Why Sinovac Biotech, Burlington Stores, and ZIOPHARM Oncology Are Today's 3 Best Stocks

The S&P makes up nearly all of yesterday's lost ground, while Sinovac, Burlington, and ZIOPHARM all rise by double digits.

Wednesday 3/5 Insider Buying Report: XON, CLGX

How Designer Microbes and the Organism Industry Will Reshape Our World

Many investors are captivated by the future of companies such as Tesla Motors and 3-D Systems -- and the potential creation of shareholder value on a scale that will be difficult to match. But are investors overlooking an even more promising industry with a brighter future?

Intrexon: Living Better Through Synthetic Biology?

3 Synthetic Biology Stocks That Can Help You Grow in 2014 (and Beyond)

Large-scale genome editing can create entirely new organisms, but it can also create a number of growth opportunities for your portfolio. Here's how Agilent Technologies, Intrexon, and Solazyme can keep your portfolio chugging along in 2014.

5 Unbelievable (but Real) Technologies Made Possible by Synthetic Biology

The synthetic biology industry has erupted in recent years. The technological breakthroughs can touch numerous industries, from health care to marijuana production.

See More XON News...




INTREXON CORP Website: http://www.dna.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks